COX-2 expression in papillary thyroid carcinoma (PTC) in cytological material obtained by fine needle aspiration biopsy (FNAB)
2011

COX-2 Expression in Papillary Thyroid Carcinoma

Sample size: 23 publication Evidence: moderate

Author Information

Author(s): Kinga Krawczyk-Rusiecka, Katarzyna Wojciechowska-Durczyńska, Anna Cyniak-Magierska, Zbigniew Adamczewski, Elżbieta Gałecka, Andrzej Lewiński

Primary Institution: Medical University of Lodz, Polish Mother's Memorial Hospital - Research Institute

Hypothesis

The study investigates the role of COX-2 expression in the pathogenesis of papillary thyroid carcinoma (PTC).

Conclusion

COX-2 gene expression is higher in patients with PTC compared to those with non-toxic nodular goitre.

Supporting Evidence

  • COX-2 gene expression was significantly higher in PTC compared to benign thyroid lesions.
  • Statistical analysis showed a significant difference in COX-2 expression with a p-value of 0.021.
  • Previous studies have indicated COX-2 overexpression in various types of cancers.

Takeaway

This study found that a specific protein called COX-2 is more active in a type of thyroid cancer, which might help us understand how this cancer develops.

Methodology

The study evaluated COX-2 expression in cytological material from 23 patients diagnosed with PTC using real-time PCR.

Limitations

The variability in COX-2 expression among subjects requires further clinical data and tumor progression analysis.

Participant Demographics

The study included 23 patients, with a mix of genders and ages ranging from 24 to 87 years.

Statistical Information

P-Value

0.021

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1756-6614-4-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication